Evidence map›Paper›PMID 37006237›Full record

ArticleFrontiers in immunology2023

The impact of hepatocyte-specific deletion of hypoxia-inducible factors on the development of polymicrobial sepsis with focus on GR and PPARα function.

Tineke Vanderhaeghen, Steven Timmermans, Melanie Eggermont, Deepika Watts, Jolien Vandewalle, Charlotte Wallaeys, Louise Nuyttens, Joyca De Temmerman, Tino Hochepied, Sylviane Dewaele and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Tineke VanderhaeghenFlanders Institute for Biotechnology (VIB) Center for Inflammation Research, Ghent, Belgium.
Steven TimmermansFlanders Institute for Biotechnology (VIB) Center for Inflammation Research, Ghent, Belgium.
Melanie EggermontFlanders Institute for Biotechnology (VIB) Center for Inflammation Research, Ghent, Belgium.
Deepika WattsDepartment of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.
Jolien VandewalleFlanders Institute for Biotechnology (VIB) Center for Inflammation Research, Ghent, Belgium.
Charlotte WallaeysFlanders Institute for Biotechnology (VIB) Center for Inflammation Research, Ghent, Belgium.
Louise NuyttensFlanders Institute for Biotechnology (VIB) Center for Inflammation Research, Ghent, Belgium.
Joyca De TemmermanDepartment of Nutrition, Genetics, and Ethology, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium.
Tino HochepiedFlanders Institute for Biotechnology (VIB) Center for Inflammation Research, Ghent, Belgium.
Sylviane DewaeleFlanders Institute for Biotechnology (VIB) Center for Inflammation Research, Ghent, Belgium.
Joke Vanden BergheFlanders Institute for Biotechnology (VIB) Center for Inflammation Research, Ghent, Belgium.
Niek SandersDepartment of Nutrition, Genetics, and Ethology, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium.
Ben WielockxDepartment of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.
Rudi BeyaertFlanders Institute for Biotechnology (VIB) Center for Inflammation Research, Ghent, Belgium.
Claude LibertFlanders Institute for Biotechnology (VIB) Center for Inflammation Research, Ghent, Belgium.
Ghent University · BEVIB-UGent Center for Inflammation Research · BEVlaams Instituut voor Biotechnologie · BEDeutsche Forschungsgemeinschaft · DETechnische Universität Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Polymicrobial sepsis causes acute anorexia (loss of appetite), leading to lipolysis in white adipose tissue and proteolysis in muscle, and thus release of free fatty acids (FFAs), glycerol and gluconeogenic amino acids. Since hepatic peroxisome proliferator-activated receptor alpha (PPARα) and glucocorticoid receptor (GR) quickly lose function in sepsis, these metabolites accumulate (causing toxicity) and fail to yield energy-rich molecules such as ketone bodies (KBs) and glucose. The mechanism of PPARα and GR dysfunction is not known. Methods & results: We investigated the hypothesis that hypoxia and/or activation of hypoxia inducible factors (HIFs) might play a role in these issues with PPARα and GR. After cecal ligation and puncture (CLP) in mice, leading to lethal polymicrobial sepsis, bulk liver RNA sequencing illustrated the induction of the genes encoding HIF1α and HIF2α, and an enrichment of HIF-dependent gene signatures. Therefore, we generated hepatocyte-specific knock-out mice for HIF1α, HIF2α or both, and a new HRE-luciferase reporter mouse line. After CLP, these HRE-luciferase reporter mice show signals in several tissues, including the liver. Hydrodynamic injection of an HRE-luciferase reporter plasmid also led to (liver-specific) signals in hypoxia and CLP. Despite these encouraging data, however, hepatocyte-specific HIF1α and/or HIF2α knock-out mice suggest that survival after CLP was not dependent on the hepatocyte-specific presence of HIF proteins, which was supported by measuring blood levels of glucose, FFAs, and KBs. The HIF proteins were also irrelevant in the CLP-induced glucocorticoid resistance, but we found indications that the absence of HIF1α in hepatocytes causes less inactivation of PPARα transcriptional function. Conclusion: We conclude that HIF1α and HIF2α are activated in hepatocytes in sepsis, but their contribution to the mechanisms leading to lethality are minimal.

Indexed as

PPAR alphaSepsisAnimalsGlucoseHepatocytesHypoxiaLuciferasesMiceMice, KnockoutReceptors, GlucocorticoidGlucoseLuciferasesPPAR alphaReceptors, Glucocorticoiddetectionglucocorticoids (GCs)hypoxiametabolismPPARalphasepsis

Identifiers

PMID37006237
PMCPMC10060827
OpenAlexW4327606217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.